Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study

PURPOSE: Histological markers that differentiate benign and malignant pediatric adrenocortical tumors (ACTs) are lacking. Previous studies have implicated an association of major histocompatibility complex (MHC) class II expression with ACT prognosis. Here we determined the expression of MHC class I...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Pinto, Emilia Modolo, Rodriguez-Galindo, Carlos, Choi, John Kim, Pounds, Stanley, Liu, Zhifa, Neale, Geoff, Finkelstein, David, Hicks, John, Pappo, Alberto S., Figueiredo, Bonald, Ribeiro, Raul C., Zambetti, Gerard P.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159323/
https://ncbi.nlm.nih.gov/pubmed/27307598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2738
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares